National Oct 2, 2020
The government is trying to secure enough vaccines by the first half of 2021 to administer to all members of the public.
The government is trying to secure enough vaccines by the first half of 2021 to administer to all members of the public.
Under a plan that is currently being discussed, the government is considering prioritizing medical workers, the elderly and people who have underlying illnesses.
Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021
In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.
Older people and young children in Japan to get flu shot priority
The flu vaccine supply for this winter is expected to cover some 63 million people, according to the health ministry.
Developing countries don’t want to wait for superpowers’ vaccines
After COVID-19’s emergence in Buenos Aires led to a strict lockdown in March, Juliana Cassataro and her fellow vaccine researchers grew concerned. The U.S., Europe and China had already revved up their quests to obtain shots; how far back in line would Argentina have ...
Facebook’s dilemma: How to police claims about unproven virus vaccines
Since the World Health Organization declared the novel coronavirus an international health emergency in January, Facebook Inc. has removed more than 7 million pieces of content with false claims about the virus that could pose an immediate health risk to people who believe them. The ...
Unsung T cells take over immune response when coronavirus antibodies wane
The world's vaccine hunters are hailing the emergence of these crucial cells as they race to find a cure for the deadly contagion.
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
China's CanSino in talks for COVID-19 vaccine Phase III trial overseas
Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday. China's success in driving down COVID-19 infections has made it harder to conduct large-scale ...
The fight over a coronavirus vaccine will get ugly
Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.
How Moderna execs are cashing in during the race to develop COVID-19 vaccine
Biotech firm Moderna Inc. could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash. In the meantime, the firm’s chief executive is pocketing millions of ...
The race to develop a COVID-19 vaccine, and Japan's place in it
With more than 140 coronavirus measures in development and 13 undergoing trials, hopes are being pinned on one being approved in the near future.